Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Julia C. Espel, Hannah L. Palac, Joanne F. Cullina, Alexandria P. Clarke, Susanna A. McColley, Michelle H. Prickett, Manu Jain
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMC 2017-11-01
Serie:BMC Pulmonary Medicine
Ämnen:
Antibiotics
Bronchiectasis
Cystic fibrosis
Exacerbation
Outcomes Pseudomonas aeruginosa
Länkar:http://link.springer.com/article/10.1186/s12890-017-0503-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk